Title:
CONJUGATE VACCINE TARGETING DISORDER-CAUSING IN VIVO PROTEIN
Document Type and Number:
Japanese Patent JP2021183638
Kind Code:
A
Abstract:
To provide a vaccine which contains a complex of a carrier protein conjugated to an epitope of a disease-causing in vivo protein and has reduced antigenicity of the carrier protein and an effective antibody production capability as a vaccine.SOLUTION: A vaccine comprises a complex of a peptide consisting of an amino acid sequence that is the same or substantially the same as the amino acid sequence of SEQ ID NO: 1 and an epitope of a disease-causing in vivo protein. The disease-causing in vivo protein is preferably selected from a group consisting of DPP4, IL-17A, IgE, S100A9 and PCSK9.SELECTED DRAWING: None
Inventors:
NAKAGAMI YOSHINORI
MORISHITA RYUICHI
TENMAN AKIKO
MORISHITA RYUICHI
TENMAN AKIKO
Application Number:
JP2021137656A
Publication Date:
December 02, 2021
Filing Date:
August 26, 2021
Export Citation:
Assignee:
UNIV OSAKA
FUNPEP CO LTD
FUNPEP CO LTD
International Classes:
A61K39/00; A61K38/08; A61K38/10; A61K47/64; A61P3/06; A61P17/06; A61P35/00; C07K19/00
Foreign References:
| WO2014157485A1 | 2014-10-02 | |||
| WO2010089940A1 | 2010-08-12 |
Attorney, Agent or Firm:
Ryu Iwatani
Previous Patent: Pharmaceutical composition
Next Patent: Physiologically balanced, injectable formulation of phosnetsupitant
Next Patent: Physiologically balanced, injectable formulation of phosnetsupitant